Dr. Simon Sheard, D.O

NPI: 1083926877
Total Payments
$25,172
2024 Payments
$2,629
Companies
10
Transactions
42
Medicare Patients
1,441
Medicare Billing
$123,773

Payment Breakdown by Category

Consulting$21,907 (87.0%)
Travel$2,103 (8.4%)
Food & Beverage$1,161 (4.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $21,907 16 87.0%
Travel and Lodging $2,103 4 8.4%
Food and Beverage $1,161 22 4.6%

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $18,700 25 $0 (2022)
Genentech USA, Inc. $3,710 6 $0 (2021)
ROCHE MOLECULAR SYSTEMS, INC. $2,400 2 $0 (2024)
Roche Diagnostics Corporation $123.43 1 $0 (2024)
Janssen Pharmaceuticals, Inc $105.24 1 $0 (2024)
Amgen Inc. $60.53 3 $0 (2018)
Sanofi Pasteur Inc. $21.41 1 $0 (2018)
Cranial Technologies, Inc $18.93 1 $0 (2018)
Novartis Pharmaceuticals Corporation $16.69 1 $0 (2018)
PFIZER INC. $15.04 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,629 4 ROCHE MOLECULAR SYSTEMS, INC. ($2,400)
2022 $5,758 11 ACADIA Pharmaceuticals Inc ($5,758)
2021 $820.00 1 Genentech USA, Inc. ($820.00)
2020 $4,250 2 ACADIA Pharmaceuticals Inc ($4,250)
2019 $6,343 8 ACADIA Pharmaceuticals Inc ($3,452)
2018 $5,372 16 ACADIA Pharmaceuticals Inc ($5,240)

All Payment Transactions

42 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/06/2024 ROCHE MOLECULAR SYSTEMS, INC. Consulting Fee Cash or cash equivalent $300.00 General
04/11/2024 ROCHE MOLECULAR SYSTEMS, INC. Consulting Fee Cash or cash equivalent $2,100.00 General
03/14/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $105.24 General
Category: Neuroscience
02/15/2024 Roche Diagnostics Corporation Food and Beverage In-kind items and services $123.43 General
Category: Diagnostics Information Solutions
05/25/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $29.03 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/25/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $21.47 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $4,500.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee In-kind items and services $462.96 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee In-kind items and services $426.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $112.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee In-kind items and services $61.75 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee In-kind items and services $46.90 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $37.74 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee In-kind items and services $37.47 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/24/2022 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $22.88 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/14/2021 Genentech USA, Inc. Consulting Fee Cash or cash equivalent $820.00 General
10/09/2020 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $1,750.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
08/07/2020 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
12/16/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $112.50 General
Category: PARKINSONS DISEASE PSYCHOSIS
04/25/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $3,114.86 General
Category: PARKINSONS DISEASE PSYCHOSIS
03/28/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Consulting Fee Cash or cash equivalent $225.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
02/27/2019 Genentech USA, Inc. Non-Covered Product (Drug) Food and Beverage In-kind items and services $187.42 General
Category: None
02/26/2019 Genentech USA, Inc. Non-Covered Product (Drug) Consulting Fee Cash or cash equivalent $1,600.00 General
Category: None
02/26/2019 Genentech USA, Inc. Non-Covered Product (Drug) Travel and Lodging In-kind items and services $752.36 General
Category: None
02/26/2019 Genentech USA, Inc. Non-Covered Product (Drug) Travel and Lodging In-kind items and services $263.35 General
Category: None

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 2 64 67 $15,217 $2,475
2021 15 736 1,391 $200,872 $68,260
2020 15 641 1,270 $186,985 $53,038
Total Patients
1,441
Total Services
2,728
Medicare Billing
$123,773
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 45 47 $11,797 $1,878 15.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 19 20 $3,420 $597.32 17.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 226 431 $108,181 $37,670 34.8%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2021 82 82 $13,144 $5,447 41.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 36 36 $10,584 $4,678 44.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 67 78 $13,338 $4,539 34.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 29 50 $13,300 $3,966 29.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 30 61 $11,285 $3,323 29.5%
20610 Aspiration and/or injection of large joint or joint capsule Office 2021 27 55 $9,680 $2,599 26.8%
77067 Screening mammography of both breasts Office 2021 23 23 $5,750 $2,113 36.8%
G0008 Administration of influenza virus vaccine Office 2021 88 88 $4,488 $1,454 32.4%
99211 Established patient outpatient visit, minimal presenting problem Office 2021 17 42 $5,334 $674.12 12.6%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 12 12 $2,232 $621.06 27.8%
83036 Hemoglobin a1c level Office 2021 39 48 $1,296 $451.25 34.8%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2021 34 305 $983.60 $293.37 29.8%
85610 Blood test, clotting time Office 2021 14 68 $748.00 $291.72 39.0%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 12 12 $528.00 $139.08 26.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 248 463 $116,213 $30,724 26.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 33 33 $9,702 $3,763 38.8%
90670 Pneumococcal vaccine for injection into muscle Office 2020 15 15 $8,631 $3,452 40.0%
20610 Aspiration and/or injection of large joint or joint capsule Office 2020 32 77 $12,760 $3,065 24.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 52 60 $10,260 $2,952 28.8%
90694 Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage Office 2020 41 41 $6,253 $2,501 40.0%
77067 Mammography of both breasts Office 2020 23 23 $5,750 $2,193 38.1%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 16 16 $6,128 $1,603 26.2%

About Dr. Simon Sheard, D.O

Dr. Simon Sheard, D.O is a Family Medicine healthcare provider based in Tempe, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1083926877.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simon Sheard, D.O has received a total of $25,172 in payments from pharmaceutical and medical device companies, with $2,629 received in 2024. These payments were reported across 42 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($21,907).

As a Medicare-enrolled provider, Sheard has provided services to 1,441 Medicare beneficiaries, totaling 2,728 services with total Medicare billing of $123,773. Data is available for 3 years (2020–2022), covering 32 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Tempe, AZ
  • Active Since 07/08/2010
  • Last Updated 04/17/2024
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1083926877

Products in Payments

  • NUPLAZID (Drug) $18,700
  • Non-Covered Product (Drug) $2,890
  • SPRAVATO (Drug) $105.24
  • Repatha (Biological) $44.22
  • MENACTRA (Drug) $21.41
  • Doc Band (Device) $18.93
  • PREVNAR - 13 (Biological) $15.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Tempe